| Recruiting | A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Nove NCT06720896 | Aperta Biosciences, LLC | Phase 2 |
| Recruiting | Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment NCT07431385 | Fidia Farmaceutici s.p.a. | N/A |
| Completed | Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation NCT06795165 | Eye Research Foundation, Inc. | Phase 4 |
| Completed | Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topica NCT07451678 | Instituto de Oftalmología Fundación Conde de Valenciana | Phase 4 |
| Recruiting | Photobiomodulation With REd vs BluE Light (REBEL) NCT06371300 | Aston University | N/A |
| Terminated | A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment NCT06400511 | Famy Life Sciences, a Viatris Company | Phase 3 |
| Active Not Recruiting | Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex NCT06054217 | Tarsus Pharmaceuticals, Inc. | Phase 2 |
| Completed | Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland D NCT06520007 | University of Milan | — |
| Completed | Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study NCT05629390 | LianBio LLC | Phase 3 |
| Completed | Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD NCT05454956 | Tarsus Pharmaceuticals, Inc. | Phase 2 |
| Unknown | 0.01% Hypochlorous Acid in the Treatment of Blepharitis NCT05608980 | Eye & ENT Hospital of Fudan University | N/A |
| Completed | Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry NCT05062564 | Azienda Ospedaliero-Universitaria Careggi | N/A |
| Completed | Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis NCT04784091 | Tarsus Pharmaceuticals, Inc. | Phase 3 |
| Unknown | Analysis of the Results of Intense Pulsed Light Treatment Previously to Laser Refractive Surgery NCT05139511 | Vissum, Instituto Oftalmológico de Alicante | N/A |
| Unknown | Probiotics for Blepharitis in Adults and Children NCT04742855 | University of Molise | — |
| Completed | Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis NCT04675242 | Nicox Ophthalmics, Inc. | Phase 2 |
| Completed | Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis NCT04475432 | Tarsus Pharmaceuticals, Inc. | Phase 2 / Phase 3 |
| Recruiting | Evaluation of SUMMIT BRUSH in Treatment of Blepharitis NCT04603222 | University of Notre Dame | N/A |
| Unknown | Facial Demodicosis and Ocular Demodicosis NCT04377841 | National Taiwan University Hospital | — |
| Completed | Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharit NCT03926026 | Nicox Ophthalmics, Inc. | Phase 2 |
| Completed | Corneal Epithelial Stem Cells and Dry Eye Disease NCT03302273 | Sloan W. Rush, MD | N/A |
| Unknown | Short-term Effects on Tear Film (Baby Shampoo vs Blephasol) NCT04858113 | University of Plymouth | N/A |
| Unknown | DRy Eye Outcome and Prescription Study NCT03652415 | Guy's and St Thomas' NHS Foundation Trust | — |
| Unknown | Antimicrobial and Clinical Efficacy of Cliradex® as Compared With I-Lid'n Lash® Hygiene in Treating Blephariti NCT03422146 | Ottawa Hospital Research Institute | N/A |
| Terminated | Ocular Comfort and Inflammation in Lid Hygiene Therapy NCT02938078 | Minnesota Eye Consultants, P.A. | N/A |
| Completed | Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa NCT02386774 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Unknown | Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora NCT02455895 | NovaBay Pharmaceuticals, Inc. | N/A |
| Completed | Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease NCT02218489 | Kala Pharmaceuticals, Inc. | Phase 2 |
| Completed | Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery NCT01808560 | TearScience, Inc. | N/A |
| Terminated | Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis NCT01560962 | Southern California Institute for Research and Education | N/A |
| Completed | Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis NCT01408082 | Sun Pharmaceutical Industries Limited | Phase 3 |
| Completed | Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepha NCT01478256 | John, George, M.D. | Phase 4 |
| Terminated | A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) NCT01269658 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Blephacura Versus Baby Shampoo to Treat Blepharitis NCT01115192 | University of Cologne | N/A |
| Completed | A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of NCT01102244 | Alcon Research | Phase 3 |
| Completed | Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis NCT01089608 | Laboratoires Thea | Phase 2 |
| Completed | Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivit NCT01028027 | Bausch & Lomb Incorporated | Phase 3 |
| Completed | Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes NCT00796926 | Louis Tong | Phase 3 |
| Completed | The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four- NCT00894530 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-W NCT00892970 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Tea Tree Oil in the Treatment of Chronic Blepharitis NCT01073150 | Federal University of São Paulo | Phase 2 |
| Completed | Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis NCT01357538 | Ursapharm Arzneimittel GmbH | Phase 4 |
| Completed | Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunct NCT00732446 | Federal University of São Paulo | Phase 3 |
| Completed | Lipids of the Human Tear Film and Their Effect on Tear Stability NCT00803452 | University of Louisville | Phase 4 |
| Completed | Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis NCT00656539 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis NCT00629590 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis NCT00629941 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis NCT00629980 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Treatment of Patients With Blepharitis and Facial Rosacea NCT00560703 | Galderma R&D | Phase 2 |
| Completed | Evaluation and Treatment of Patients With Corneal and External Diseases NCT00008541 | National Eye Institute (NEI) | — |